The decision to greenlight Aduhelm has drawn widespread scrutiny, and came over the objections of independent advisers to the FDA and other experts who said there was little evidence of its effectiveness.
Related posts:
Johnson & Johnson vaccine hits production snags
Biden taps D.C. veteran David Kessler to head Warp Speed
The crash landing of ‘Operation Warp Speed’
‘Nobody is telling you what to say’: Fauci regains the spotlight under Biden
Abbott: Texas mask mandate rollback ‘isn’t going to make that big of a change’
CDC director: Mask-wearing will ‘be hard to let go’ despite new guidance
Supreme Court pulls Biden into an abortion fight he didn’t want
IMF chief: 1 billion vaccine doses only a start
Top U.S. officials see booster shots as inevitable
Biden’s biomedical research agency dropped from social spending bill
Biden poised to nominate Califf as FDA chief
Chicago mayor tests positive for Covid a day after announcing school reopening deal
